CN Stock MarketDetailed Quotes

688276 Changchun Bcht Biotechnology

Watchlist
  • 38.55
  • +0.02+0.05%
Market Closed Apr 26 15:00 CST
15.92BMarket Cap29.29P/E (TTM)

Changchun Bcht Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Changchun Bcht Biotechnology Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 20, 2024

Revenue(YoY)

270.29M

+50.64%
EPS(YoY)

0.15

+275.00%
Analyst Rating

Strong Buy

Apr 27, 2024

Changchun Bcht Biotechnology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.105B--
--2024/FY-- / 2.487B--
Mar 20, 20242023/FY1.825B / 1.889B--
Mar 30, 20232022/FY1.071B / 1.441B--
Mar 17, 20222021/FY1.202B / 1.302B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 3.105B--
--2024/FY-- / 2.487B--
Mar 20, 20242023/FY1.825B / 1.889B--
Mar 30, 20232022/FY1.071B / 1.441B--
Mar 17, 20222021/FY1.202B / 1.302B--

Changchun Bcht Biotechnology Earnings Reports

  • Changchun Baike Biotechnology Co., Ltd. report for the first quarter of 2024

    Apr 20 00:00

  • Voluntary Disclosure Notice of Changchun Baike Biotechnology Co., Ltd. Results Forecast for the First Quarter of 2024

    Apr 8 00:00

  • Summary of the 2023 Annual Report of Changchun Baike Biotechnology Co., Ltd.

    Mar 20 00:00

  • Changchun Baike Biotechnology Co., Ltd. 2023 Annual Report

    Mar 20 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 27, 2024

    Strong Buy

    • Strong Buy

      81.25%

    • Buy

      18.75%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg